The TaqIB and −629C>A polymorphisms at the cholesteryl ester transfer protein locus: associations with lipid levels in a multiethnic population. The 1998 Singapore National Health Survey

The Singapore population comprises Chinese, Malays and Asian Indians. Within this population, Asian Indians have the highest rates of coronary heart disease, whereas Chinese have the lowest. Conversely, Indians have the lowest high‐density lipoprotein cholesterol (HDL‐C) concentrations, followed by Malays and Chinese. We studied the TaqIB and −629C>A polymorphisms at the CETP locus in 1300 Chinese, 364 Malay and 282 Asian Indian men, and in 1558 Chinese, 397 Malay and 306 Asian Indian women, to determine whether these polymorphisms are responsible for the ethnic difference in HDL‐C concentration. The frequency of the B2 allele in Chinese, Malays and Indians was 0.384, 0.339 and 0.449 in men, and 0.379, 0.329 and 0.415 in women, respectively (p < 0.001). For the A‐629 allele, the relative frequencies were 0.477, 0.423 and 0.592 in men and 0.486, 0.416 and 0.575 in women (p < 0.001). The two polymorphisms were in linkage disequilibrium (D / Dmax= 0.9772, p < 0.00001). The B2 and the A‐629 alleles were associated with increased HDL‐C concentrations in a dose‐dependent manner. The B2 allele continued to show an association with HDL‐C concentration, even after controlling for the genotype at position −629. Dietary cholesterol showed a significant interaction with the TaqIB polymorphism in determining HDL‐C concentrations in Indians and Malays, but not in Chinese. In conclusion, the high frequencies of these polymorphisms in Asian Indians could not explain the observed ethnic differences in HDL‐C concentration. Moreover, we observed an ethnic‐specific interaction among dietary cholesterol, the TaqIB polymorphism and HDL‐C concentrations.

[1]  J. Rotter,et al.  Linkage analysis of the genetic determinants of high density lipoprotein concentrations and composition: evidence for involvement of the apolipoprotein A-II and cholesteryl ester transfer protein loci , 1994, Human Genetics.

[2]  M. Taskinen,et al.  Polymorphisms of the gene encoding cholesterol ester transfer protein and serum lipoprotein levels in subjects with and without coronary heart disease , 1991, Human Genetics.

[3]  A. Evans,et al.  A novel cholesteryl ester transfer protein promoter polymorphism (-971G/A) associated with plasma high-density lipoprotein cholesterol levels. Interaction with the TaqIB and -629C/A polymorphisms. , 2002, Atherosclerosis.

[4]  G. Franceschini Epidemiologic evidence for high-density lipoprotein cholesterol as a risk factor for coronary artery disease. , 2001, The American journal of cardiology.

[5]  Y. T. Lee,et al.  Influence of CETP gene variation on plasma lipid levels and coronary heart disease: a survey in Taiwan. , 2001, Atherosclerosis.

[6]  V. Gudnason,et al.  The -629C>A polymorphism in the CETP gene does not explain the association of TaqIB polymorphism with risk and age of myocardial infarction in Icelandic men. , 2001, Atherosclerosis.

[7]  A. Rantala,et al.  Variation at the cholesteryl ester transfer protein gene in relation to plasma high density lipoproteins cholesterol levels and carotid intima‐media thickness , 2001, European journal of clinical investigation.

[8]  R. Schwartz Racial profiling in medical research. , 2001, The New England journal of medicine.

[9]  P. Deurenberg,et al.  Can dietary factors explain differences in serum cholesterol profiles among different ethnic groups (Chinese, Malays and Indians) in Singapore? , 2001, Asia Pacific journal of clinical nutrition.

[10]  L. Hsu,et al.  Genetic variations in the cholesteryl ester transfer protein gene and high density lipoprotein cholesterol levels in Taiwanese Chinese , 2001, Human Genetics.

[11]  S. Chew,et al.  Levels of cardiovascular disease risk factors in Singapore following a national intervention programme. , 2001, Bulletin of the World Health Organization.

[12]  B. Su,et al.  Natives or immigrants: modern human origin in east asia , 2000, Nature Reviews Genetics.

[13]  D. Corella,et al.  Association of TaqIB polymorphism in the cholesteryl ester transfer protein gene with plasma lipid levels in a healthy Spanish population. , 2000, Atherosclerosis.

[14]  H. Mabuchi,et al.  Cholesteryl ester transfer protein and atherosclerosis , 2000, Current opinion in lipidology.

[15]  G. Luc,et al.  Taq1B CETP polymorphism, plasma CETP, lipoproteins, apolipoproteins and sex differences in a Jewish population sample characterized by low HDL-cholesterol. , 2000, Atherosclerosis.

[16]  P. Wilson,et al.  Association of cholesteryl ester transfer protein-TaqIB polymorphism with variations in lipoprotein subclasses and coronary heart disease risk: the Framingham study. , 2000, Arteriosclerosis, thrombosis, and vascular biology.

[17]  K. Hughes,et al.  Incidence of ischaemic heart disease and stroke in Chinese, Malays and Indians in Singapore: Singapore Cardiovascular Cohort Study. , 2000, Annals of the Academy of Medicine, Singapore.

[18]  F. Cambien,et al.  New functional promoter polymorphism, CETP/-629, in cholesteryl ester transfer protein (CETP) gene related to CETP mass and high density lipoprotein cholesterol levels: role of Sp1/Sp3 in transcriptional regulation. , 2000, Arteriosclerosis, thrombosis, and vascular biology.

[19]  T. Wilt,et al.  Gemfibrozil for the secondary prevention of coronary heart disease in men with low levels of high-density lipoprotein cholesterol. Veterans Affairs High-Density Lipoprotein Cholesterol Intervention Trial Study Group. , 1999, The New England journal of medicine.

[20]  G. Ginsburg,et al.  Characterization of a cholesterol response element (CRE) in the promoter of the cholesteryl ester transfer protein gene: functional role of the transcription factors SREBP-1a, -2, and YY1. , 1999, Journal of lipid research.

[21]  V. Gudnason,et al.  Cholesteryl ester transfer protein gene effect on CETP activity and plasma high‐density lipoprotein in European populations , 1999, European journal of clinical investigation.

[22]  S. Emmanuel,et al.  Prevalence of diabetes and ethnic differences in cardiovascular risk factors. The 1992 Singapore National Health Survey. , 1999, Diabetes care.

[23]  V. Gudnason,et al.  Cholesteryl ester transfer protein gene effect on CETP activity and plasma high-density lipoprotein in European populations. The EARS Group. , 1999, European journal of clinical investigation.

[24]  Carol Ewing Garber,et al.  ACSM Position Stand: The Recommended Quantity and Quality of Exercise for Developing and Maintaining Cardiorespiratory and Muscular Fitness, and Flexibility in Healthy Adults , 1998 .

[25]  J. Boer,et al.  Heterogeneity at the CETP gene locus. Influence on plasma CETP concentrations and HDL cholesterol levels. , 1997, Arteriosclerosis, thrombosis, and vascular biology.

[26]  P. Barter,et al.  Molecular mechanisms of reverse cholesterol transport , 1996, Current opinion in lipidology.

[27]  A. Tall,et al.  Cholesteryl ester transfer proteins, reverse cholesterol transport, and atherosclerosis , 1995, Current Opinion in Lipidology.

[28]  D. Arveiler,et al.  Alcohol intake modulates the effect of a polymorphism of the cholesteryl ester transfer protein gene on plasma high density lipoprotein and the risk of myocardial infarction. , 1995, The Journal of clinical investigation.

[29]  M. Savolainen,et al.  Relation of polymorphisms in the cholesteryl ester transfer protein gene to transfer protein activity and plasma lipoprotein levels in alcohol drinkers. , 1994, Atherosclerosis.

[30]  A P Holmes,et al.  Regulation of plasma HDL cholesterol and subfraction distribution by genetic and environmental factors. Associations between the TaqI B RFLP in the CETP gene and smoking and obesity. , 1994, Arteriosclerosis and thrombosis : a journal of vascular biology.

[31]  J. Shepherd,et al.  Genetic variation in the cholesteryl ester transfer protein and apolipoprotein A-I genes and its relation to coronary heart disease in a Sri Lankan population. , 1990, Atherosclerosis.